Recent Updates
Recently added Catalysts
ACHC Positive Sentiment

Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release

Tuesday, October 13, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Acadia Healthcare Company, Inc. has announced the release date for its third quarter 2026 earnings results, which will be available after market close on November 4, 2026. Following this, a conference call for institutional investors and analysts is scheduled for November 5, 2026, at 9:00 a.m. ET. The call will be accessible via a live broadcast on their website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Acadia Healthcare is set to release its earnings, indicating ongoing business activity.
  • The scheduled conference call shows transparency and engagement with investors.
  • The release date is clearly communicated, allowing investors to prepare.

Full Press Release Details

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2026 results on Wednesday, November 4, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Thursday, November 5, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website, and the archived webcast will be a

Frequently Asked Questions

When will Acadia Healthcare release its Q3 2026 results?

Acadia Healthcare will release its Q3 2026 results on November 4, 2026.

What time is the conference call for Q3 2026 results?

The conference call is scheduled for November 5, 2026, at 9:00 a.m. ET.

Where can I listen to the conference call?

The conference call will be available live on Acadia's website in the Investors section.

Will the conference call be archived?

Yes, the archived webcast of the conference call will be available on their website.

ShareAdd on Google
Tags: ACHC Acadia Healthcare earnings release Q3 2026 conference call
Last updated: Oct 13, 2026

Biotech snapshot

Cash runway
$171M liquidity · $0M/mo burn
Low dilution risk